Skip to content

An study of effectiveness of Dementia Care Mapping intervention in nursing home settings.

An RCT study of (cost)effectiveness of Dementia Care Mapping intervention in nursing home settings.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20164
Enrollment
280
Registered
2010-05-04
Start date
2010-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Dementie

Interventions

Intervention group: 1. Dementia Care Mapping (DCM) Organisational Briefing Day
2. Staff trainings (Certified DCM User)
3. Three DCM-cycles (single cycle: observation, feed-back, development and implementation of action plan(s), evaluation actions). Controlgroup: 1. Usual Care.

Sponsors

UMC St Radboud Nijmegen, Eerstelijnsgeneeskunde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 65-up years old; 2. Diagnosed with dementia by a (psycho)geriatrician, neurologist or old age psychiatrist/psychologist 3. Who have received an assent by the nursing home physician; 4. Who display at least one neuropsychiatric symptom (CMAI, NPI-NH) such as agitation/agression, apathy, verbal and physical aggression, severe vocal and physical perseveration, significant wandering and self-harm; 5. Who have either provided informed consent themselves or by their family/legal guardian.

Exclusion criteria

Exclusion criteria: Residents who are in a terminal stage of the illness (estimated life expectancy 6 weeks) or those who are too physically unwell to spend time in common areas of the facility, will not be included in the study.

Design outcomes

Primary

MeasureTime frame
Residents: 1. Neuropsychiatric symptoms (CMAI, NPI-NH).

Secondary

MeasureTime frame
Residents: 1. Quality of life (WIB, DQol). Staff: 1. Work-stress (GHQ); 2. Stress related absenteeism and turnover; 3. Job satisfaction (MAS, VAS).

Contacts

Public ContactG. Ven, van de

IQ healthcare Postbus 9101, huispost 114

G.vandeVen@iq.umcn.nl+31 (0)243616796

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)